Description of a patient with schizophrenia and coexisting megadose lorazepam dependence with slightly expressed withdrawl symptoms during drug reduction. A case report

Schylla, A.; Scisło, P.; Badura-Brzoza, K.; Pasierb, N.

Wiadomosci Lekarskie 65(4): 243-246

2012


ISSN/ISBN: 0043-5147
PMID: 23654146
Document Number: 662706
The aim of this article is to present a patient with a megadose lorazepam dependence and slightly marked withdrawal symptoms during detoxication. The authors describe the case of 42 year old man who has been addicted to lorazepam (125 mg/d) for 2 years. On the ground of medical examination, anamnesis and hospital observation paranoid schizophrenia and lorazepam dependence syndrome was recognized. Despite relatively rapid reduction of lorazepam the withdrawal symptoms were slightly expressed. At the beginning of detoxication sleep disorders, feeling of "less looseness" and anxiety was observed. Review of medical database revealed other cases of megadose lorazepam dependence (95-300 mg/d). However in those cases withdrawal symptoms were distinct and the medical intervention was needed.

Document emailed within 1 workday
Secure & encrypted payments